Anipamil

• Description:

  Anipamil is a long-acting calcium channel blocker, used for the treatment of cardiovascular disease.

• UNSPSC:

  12352005

• Target:

  Calcium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Anipamil.html

• Purity:

  99.34

• Solubility:

  H2O : 2 mg/mL (ultrasonic; warming)

• Smiles:

  N#CC(CCCN(CCC1=CC=CC(OC)=C1)C)(CCCCCCCCCCCC)C2=CC=CC(OC)=C2

• Molecular Formula:

  C34H52N2O2

• Molecular Weight:

  520.79

• References & Citations:

  [2]Pugsley MK, et al. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia. Life Sci. 1995;57 (12) :1219-31.|[3]Jarusiripipat C, et al. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats. J Pharmacol Exp Ther. 1992 Jan;260 (1) :243-7.|[1]Pauletto P, et al. Anipamil prevents intimal thickening in the aorta of hypertensive rabbits through changes in smooth muscle cell phenotype. Am J Hypertens. 1996 Jul;9 (7) :687-94.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 3

• CAS Number:

  83200-10-6